Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CABG (coronary artery bypass surgery) comes under pressure from new cardiovascular technologies, says Theta report

This article was originally published in Clinica

Executive Summary

New methods of treating cardiovascular disease mean that use of the gold standard coronary artery bypass surgery (CABG) is increasing more slowly than ever before. However, the way the procedure is performed is changing and by 2004 over half of all coronary bypass operations will be performed minimally invasively on beating hearts, according to a new publication by Theta Reports - Cardiac Equipment & Materials Markets Including Stents. Advances in treating transplant and angina patients and measures to prevent stents becoming blocked are likely to bring in further substantial changes to certain sections of the market over the next five years.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel